Portomesenteric Vein Thrombosis After Laparoscopic Sleeve Gastrectomy: A Single-Institution Report

Am Surg. 2023 Nov;89(11):4565-4568. doi: 10.1177/00031348221112265. Epub 2022 Jul 2.

Abstract

Laparoscopic sleeve gastrectomy (LSG) is an effective weight-loss operation. Portomesenteric vein thrombosis (PMVT) is an important complication of LSG. We identified four cases of PMVT after LSG at our institution in women aged 36-47 with BMIs ranging from 44-48 kg/m2. All presented 8-19 days postoperatively. Common symptoms were nausea, vomiting, and abdominal pain. Thrombotic risk factors were previous deep vein thrombosis and oral contraceptive use. Management included therapeutic anti-coagulation, directed thrombolysis, and surgery. Complications were readmission, bowel resection, and bleeding. Discharge recommendations ranged from 3-6 months of anticoagulation using various anticoagulants. No consensus was reached on post-treatment hypercoagulable work up or imaging. All cases required multi-disciplinary approach with Surgery, Interventional Radiology, and Hematology. As PMVT is a rare but potentially morbid complication of LSG, further development of tools that quantify preoperative thrombotic risk and clear guidance regarding use of anticoagulants are needed for prevention and treatment of PMVT following LSG.

Keywords: bariatrics; minimally invasive surgery; obesity.

MeSH terms

  • Anticoagulants / therapeutic use
  • Female
  • Gastrectomy / adverse effects
  • Gastrectomy / methods
  • Humans
  • Laparoscopy* / adverse effects
  • Laparoscopy* / methods
  • Obesity, Morbid* / complications
  • Obesity, Morbid* / surgery
  • Postoperative Complications / surgery
  • Retrospective Studies
  • Risk Factors
  • Venous Thrombosis* / drug therapy
  • Venous Thrombosis* / etiology

Substances

  • Anticoagulants